Screener
Regeneron Pharmaceuticals REGN Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's operating margin?
- Regeneron Pharmaceuticals (REGN) reported operating margin of 24.7% in Q2 2026.
- How has Regeneron Pharmaceuticals's operating margin changed year-over-year?
- Regeneron Pharmaceuticals's operating margin decreased by 8.4% year-over-year, from 27% to 24.7%.
- What is the long-term trend for Regeneron Pharmaceuticals's operating margin?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's operating margin has grown at a -9.9% compound annual growth rate (CAGR), from 42.1% to 24.9%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Regeneron Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude